Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03414658 |
|---|---|
| Brief Title: | The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer |
| First Submitted : | November 10, 2017 |
| First Submitted that Met QC Criteria : | January 26, 2018 |
| First Posted : | January 30, 2018 |
| Results First Submitted : | February 20, 2024 |
| Results First Posted with QC Comments : | March 20, 2024 |
| Results First Submitted that Met QC Criteria : | March 22, 2024 |
| Results First Posted : | April 18, 2024 |
| Last Update Submitted that Met QC Criteria : | March 22, 2024 |
| Last Update Posted : | April 18, 2024 |